Albuminuria and Diabetic Retinopathy in Type 2 Diabetes Mellitus Sankara Nethralaya Diabetic Retinopathy Epidemiology And Molecular Genetic Study (SN-DREAMS, report 12)

Diabetology & Metabolic Syndrome

Tarun Sharma²  Vaitheeswaran Kulothungan¹  Swakshyar S Pal²  Aditi Gupta²  Rajiv Raman²  Padmaja K Rani² 

[1] Department of Preventive Ophthalmology (Epidemiology and Biostatistics), 18, College Road, Sankara Nethralaya, Chennai-600 006, Tamil Nadu, India;Shri Bhagwan Mahavir Vitreoretinal Services, 18, College Road, Sankara Nethralaya, Chennai-600 006, Tamil Nadu, India

关键词: Type 2 Diabetes;    Risk factor;    Macroalbuminuria;    Microalbuminuria;    Diabetic Retinopathy;   

Others  :  817628
DOI  :  10.1186/1758-5996-3-9

 received in 2011-01-16, accepted in 2011-05-25,  发布年份 2011

【 摘 要 】

Background

The concordance of microalbuminuria and diabetic retinopathy (DR) has been well reported in persons with type 1 diabetes; however, for type 2 diabetes, there is paucity of data especially from population-based studies. The aim of this study was to estimate the prevalence of albuminuria (micro - and macroalbuminuria) among persons with type 2 diabetes and determine its role as a risk factor for presence and severity of DR.

Methods

A population-based cross sectional study was conducted in cohort of 1414 subjects with type 2 diabetes from Chennai metropolis. All the subjects underwent comprehensive eye examination including 45 degrees four-field stereoscopic digital photography. DR was clinically graded using Early Treatment Diabetic Retinopathy Study scales. A morning urine sample was tested for albuminuria. Subjects were considered to have microalbuminuria, if the urinary albumin excretion was between 30 and 300 mg/24 hours, and macroalbuminuria at more than 300 mg/24 hours. The statistical software used was SPSS for Windows, Chicago, IL. Student t-test for comparing continuous variables, and χ² test, to compare proportions amongst groups were used.

Results

The prevalence of microalbuminuria in the study subjects was 15.9% (226/1414), and that of macroalbuminuria, 2.7% (38/1414). Individuals with macroalbuminuria in comparison to micro- or normoalbuminuria showed a greater prevalence of DR (60.5% vs. 31.0% vs. 14.1%, p < 0.001), and also a greater severity of the disease (60.9% vs. 21.4 vs. 9.9, p < 0.001).

Conclusions

Every 6^th individual in the population of type 2 diabetes is likely to have albuminuria. Subjects with microalbuminuria were around 2 times as likely to have DR as those without microalbuminuria, and this risk became almost 6 times in the presence of macroalbuminuria.

【 授权许可】

   
2011 Rani et al; licensee BioMed Central Ltd.

【 参考文献 】

• [1]Wild S, Roglic G, Green A, Sicree R, King H: Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004, 27:1047-1053.
• [2]Unnikrishnan RI, Rema M, Pradeepa R, Deepa M, Shanthirani CS, Deepa R, Mohan V: Prevalence and risk factors of diabetic nephropathy in an urban South Indian population: the Chennai Urban Rural Epidemiology Study (CURES 45). Diabetes Care 2007, 30:2019-2024.
• [3]Prevalence of small vessel and large vessel disease in diabetic patients from 14 centers. The World Health Organization Multinational Study of Vascular Disease in Diabetics. Diabetes Drafting Group Diabetologia 1985, 28(Suppl):615-640.
• [4]Sobngwi E, Mbanya JC, Moukouri EN, Ngu KB: Microalbuminuria and retinopathy in a diabetic population of Cameroon. Diabetes Res Clin Pract 1999, 44:191-196.
• [5]Wirta O, Pasternack A, Mustonen J, Laippala P, Lähde Y: Retinopathy is independently related to microalbuminuria in type 2 diabetes mellitus. Clin Nephrol 1999, 51:329-334.
• [6]WHO-Magnitude and causes of Visual impairment[http://www.who.int/mediacentre/factsheets/fs282/en/] webcite 2010.
• [7]Lovestam-Adrian M, Agardh E, Agardh CD: The temporal development of retinopathy and nephropathy in type 1 diabetes mellitus during 15 years diabetes duration. Diabetes Res Clin Pract 1999, 45:15-23.
• [8]Marshall SM, Alberti KG: Comparison of the prevalence and associated features of abnormal albumin excretion in insulin-dependent and non-insulin-dependent diabetes. Q J Med 1989, 70:61-71.
• [9]Neil A, Hawkins M, Potok M, Thorogood M, Cohen D, Mann J: A prospective population-based study of microalbuminuria as a predictor of mortality in NIDDM. Diabetes Care 1993, 16:996-1003.
• [10]Retnakaran R, Cull CA, Thorne KI, Adler AI, Holman RR, UKPDS Study Group: Risk factors for renal dysfunction in type 2 diabetes: U.K. Prospective Diabetes Study 74. Diabetes 2006, 55:1832-1839.
• [11]Voutilainen-Kaunisto RM, Terasvirta ME, Uasitupa MIJ, Niskanen LK: Occurrence and predictors of retinopathy and visual acuity in Type 2 diabetic patients and control subjects 10-year follow-up from the diagnosis. J Diab Comp 2001, 15:24-33.
• [12]Olivarius NdF, Andreasen AH, Keiding N, Mogensen CE: Epidemiology of renal involvement in newly-diagnosed middle-aged and elderly diabetic patients. Cross-sectional data from the population-based study "Diabetes Care in General Practice", Denmark. Diabetologia 1993, 36:1007-1016.
• [13]Looker HC, Krakoff J, Knowler WC, Bennett PH, Klein R, Hanson RL: Longitudinal studies of incidence and progression of diabetic retinopathy assessed by retinal photography in Pima Indians. Diabetes Care 2003, 26:320-326.
• [14]Savage S, Estacio RO, Jeffers B, Schrier RW: Urinary albumin excretion as a predictor of diabetic retinopathy, neuropathy, and cardiovascular disease in NIDDM. Diabetes Care 1996, 19:1243-1248.
• [15]Agarwal S, Raman R, Paul PG, Rani PK, Uthra S, Gayathree R, McCarty C, Kumaramanickavel G, Sharma T: Sankara Nethralaya-Diabetic Retinopathy Epidemiology and Molecular Genetic Study (SN-DREAMS 1): study design and research methodology. Ophthalmic Epidemiol 2005, 12:143-153.
• [16]Goldstein DE, Little RR, Lorenz RA, Malone JI, Nathan DM, Peterson CM, American Diabetes Association: Tests of glycemia in diabetes. Diabetes Care 2003, 26(Suppl 1):106-108.
• [17]Le Floch JP, Marre M, Rodier M, Passa P: Interest of Clinitek Microalbumin in screening for microalbuminuria: results of a multicentre study in 302 diabetic patients. Diabetes Metab 2001, 27:36-39.
• [18]Gansevoort RT, Verhave JC, Hillege HL, Burgerhof JG, Bakker SJ, de Zeeuw D, de Jong PE, for the PREVEND Study Group: The validity of screening based on spot morning urine samples to detect subjects with microalbuminuria in the general population. Kidney Int Suppl 2005, 94:S28-35.
• [19]Sarafidis PA, Riehle J, Bogojevic Z, Basta E, Chugh A, Bakris GL: A comparative evaluation of various methods for microalbuminuria screening. Am J Nephrol 2008, 28:324-329.
• [20]Molitch ME, DeFronzo RA, Franz MJ, Keane WF, Mogensen CE, Parking HH, Steffes MW, American Diabetes Association: Nephropathy in Diabetes. Diabetes Care 2004, 27(Suppl 1):79-83.
• [21]Klein R, Klein BE, Magli YL, Brothers RJ, Meuer SM, Moss SE, Davis MD: An alternative method of grading diabetic retinopathy. Ophthalmology 1986, 93:1183-1187.
• [22]Raman Kutty V, Joseph A, Soman CR: High prevalence of type 2 diabetes in an urban settlement in Kerala, India. Ethn Health 1999, 4:231-239.
• [23]Gupta A, Gupta R, Sarna M, Rastogi S, Gupta VP, Kothari K: Prevalence of diabetes, impaired fasting glucose and insulin resistance syndrome in an urban Indian population. Diabetes Res Clin Pract 2003, 61:69-76.
• [24]Zargar AH, Khan AK, Masoodi SR, Laway BA, Wani AI, Bashir MI, Dar FA: Prevalence of type 2 diabetes mellitus and impaired glucose tolerance in the Kashmir Valley of the Indian subcontinent. Diabetes Res Clin Pract 2000, 47:135-146.
• [25]Ramachandran A, Snehalatha C, Kapur A, Vijay V, Mohan V, Das AK, Rao PV, Yajnik CS, Prasanna Kumar KM, Nair JD, Diabetes Epidemiology Study Group in India (DESI): High prevalence of diabetes and impaired glucose tolerance in India: National Urban Diabetes Survey. Diabetologia 2001, 44:1094-1101.
• [26]Mohan V, Deepa M, Deepa R, Shanthirani CS, Farooq S, Ganesan A, Datta M: Secular trends in the prevalence of diabetes and glucose tolerance in urban South India--the Chennai Urban Rural Epidemiology Study (CURES-17). Diabetologia 2006, 49:1175-1178.
• [27]Molitch ME, Steffes MW, Cleary PA, Nathan DM: Baseline analysis of renal function in the Diabetes Control and Complications Trial. The Diabetes Control and Complications Trial Research Group [corrected]. Kidney Int 1993, 43:668-674.
• [28]Gall MA, Hougaard P, Borch-Johnsen K, Parving HH: Risk factors for development of incipient and overt diabetic nephropathy in patients with non-insulin dependent diabetes mellitus: prospective, observational study. BMJ 1997, 314:783-788.
• [29]Phoksunthorn T, Thatsnarong D: Retinopathy and macro-albuminuria in type 2 diabetic patients. J Med Assoc Thai 2007, 90:684-687.
• [30]Park JY, Kim HK, Chung YE, Kim SW, Hong SK, Lee KU: Incidence and determinants of microalbuminuria in Koreans with type 2 diabetes. Diabetes Care 1998, 21:530-534.
• [31]Singh SK, Behre A, Singh MK: Diabetic retinopathy and microalbuminuria in lean type 2 diabetes mellitus. J Assoc Physicians India 2001, 49:439-441.
• [32]Durruty P, Carpentier C, Krause P, Garcia de los RM: Evaluation of retinal involvement in type 2 diabetics with microalbuminuria. Rev Med Chil 2000, 128:1085-1092.
• [33]Boelter MC, Gross JL, Canani LH, Costa LA, Lisboa HR, Três GS, Lavinsky J, Azevedo MJ: Proliferative diabetic retinopathy is associated with microalbuminuria in patients with type 2 diabetes. Braz J Med Biol Res 2006, 39:1033-1039.
• [34]Cignarelli M, De Cicco ML, Damato A, Paternostro A, Pagliarini S, Santoro S, Cardia L, De Pergola G, Giorgino R: High systolic blood pressure increases prevalence and severity of retinopathy in NIDDM patients. Diabetes Care 1992, 15:1002-1008.
• [35]Cruickshanks KJ, Ritter LL, Klein R, Moss SE: The association of microalbuminuria with diabetic retinopathy. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. Ophthalmology 1993, 100:862-867.
• [36]Potisat S, Srisubat A, Krairttichai U, Jongsareejit A: The relationship between microalbuminuria by using urine dipsticks and diabetic retinopathy in type 2 diabetes. J Med Assoc Thai 2008, 91:846-851.
• [37]Shwartz MM, Lewis EJ, Leonard-Martin T, Lewis JB, Batlle D: Renal pathology patterns in type II diabetes mellitus: relationship with retinopathy. The Collaborative Study Group. Nephrol Dial Transplant 1998, 13:2547-2552.
• [38]Olivarius NdF, Nielsen NV, Andreasen AH: Diabetic retinopathy in newly diagnosed middle-aged and elderly diabetic patients. Prevalence and interrelationship with microalbuminuria and triglycerides. Graefe's Arch Clin Exp Ophthalmol 2001, 239:664-672.
• [39]Raffaitin C, Lasseur C, Chauveau P, Barthe N, Gin H, Combe C, Rigalleau V: Nutritional status in patients with diabetes and chronic kidney disease: a prospective study. Am J Clin Nutr 2007, 85:96-101.
• [40]Stephenson JM, Fuller JH, Viberti GC, Sjolie AK, Navalesi R: Blood pressure, retinopathy and urinary albumin excretion in IDDM: the EURODIAB IDDM Complications Study. Diabetologia 1995, 38:599-603.
• [41]Deckert T, Feldt-Rasmussen B, Borch-Johnsen K, Jensen T, Kofoed-Enevoldsen A: Albuminuria reflects widespread vascular damage. The Steno hypothesis. Diabetologia 1989, 32:219-226.
• [42]Levy AP, Roguin A, Hochberg I, Herer P, Marsh S, Nakhoul FM, Skorecki K: Haptoglobin phenotype and vascular complications in patients with diabetes. N Engl J Med 2000, 343:969-70.
• [43]Nakhoul FM, Zoabi R, Kanter Y, Zoabi M, Skorecki K, Hochberg I, Leibu R, Miller B, Levy AP: Haptoglobin phenotype and diabetic nephropathy. Diabetologia 2001, 44:602-604.
• [44]Asleh R, Levy AP: In vivo and in vitro studies establishing haptoglobin as a major susceptibility gene for diabetic vascular disease. Vasc Health Risk Manag 2005, 1:19-28.
• [45]Nomiyama T, Tanaka Y, Piao L, Nagasaka K, Sakai K, Ogihara T, Nakajima K, Watada H, Kawamori R: The polymorphism of manganese superoxide dismutase is associated with diabetic nephropathy in Japanese type 2 diabetic patients. J Hum Genet 2003, 48:138-141.
• [46]Liu L, Xiang K, Zheng T, Zhan : Co-inheritance of specific genotypes of HSPG and ApoE gene increases risk of type 2 diabetic nephropathy. Mol Cell Biochem 2003, 254:353-358.
• [47]Mooyaart AL, Valk EJ, van Es LA, Bruijn JA, de Heer E, Freedman BI, Dekkers OM, Baelde HJ: Genetic associations in diabetic nephropathy: a meta-analysis. Diabetologia 2011, 54:544-553.
• [48]Stratton IM, Kohner EM, Aldington SJ, Turner RC, Holman RR, Manley SE, Matthews DR: UKPDS 50: risk factors for incidence and progression of retinopathy in type II diabetes over 6 years from diagnosis. Diabetologia 2001, 44:156-163.
• [49]Adler AI, Stratton IM, Neil HA, Yudkin JS, Matthews DR, Cull CA, Wright AD, Turner RC, Holman RR: Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study. BMJ 2000, 321:412-419.
• [50]Klein R, Klein BE, Moss SE: Prevalence of microalbuminuria in older-onset diabetes. Diabetes care 1993, 16:1325-1330.
• [51]Kim CH, Kim HK, Park JY, Park HS, Hong SK, Park SW, Lee KU: Association of microalbuminuria and atherosclerotic risk factors in non-diabetic subjects in Korea. Diabetes Res Clin Pract 1998, 40:191-199.
• [52]Manaviat MR, Afkhami M, Shoja MR: Retinopathy and microalbuminuria in type II diabetic patients. BMC Ophthalmol 2004, 4:9. BioMed Central Full Text
• [53]Lunetta M, Infantone L, Calogero A, Infantone E: Increased urinary albumin excretion is a marker of risk for retinopathy and coronary heart disease in patients with type 2 diabetes mellitus. Diabetes Res Clin Pract 1998, 40:45-51.
• [54]Olivarius NdF, Siersma V, Nielsen AB, Hansen LJ, Rosenvinge L, Mogensen CE: Predictors of mortality of patients newly diagnosed with clinical type 2 diabetes: a 5-year follow up study. BMC.Endocr.Disord 2010, 10:14. BioMed Central Full Text
• [55]Diabetes Prevention Program Research Group: The prevalence of retinopathy in impaired glucose tolerance and recent-onset diabetes in the Diabetes Prevention Program. Diabet Med 2007, 24:137-144.
• [56]Glassock RJ: Is the presence of microalbuminuria a relevant marker of kidney disease? Curr Hypertens Rep 2010, 12:364-368.
• [57]Solbu MD, Jenssen TG, Eriksen BO, Toft I: Changes in insulin sensitivity, renal function and markers of endothelial dysfunction in hypertension--the impact of microalbuminuria: a 13 year follow-up study. Metabolism 2009, 58:408-415.
• [58]Silva AM, Schaan BD, Signori LU, Plentz RD, Moreno H Jr, Bertoluci MC, Irigoyen MC: Microalbuminuria is associated with impaired arterial and venous endothelium dependent vasodilation in patients with type 2 diabetes. J Endocrinol Invest 2010, 33:696-700.
• [59]Foster MC, Keyes MJ, Larson MG, Vita JA, Mitchell GF, Meigs JB, Vasan RS, Benjamin EJ, Fox CS: Relations of measures of endothelial function and kidney disease: the Framingham Heart Study. Am J Kidney Dis 2008, 52:859-867.
• [60]Gaede P, Vedel P, Larsen N, Jensen GVH, Parving H, Pedersen O: Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 2003, 348:383-393.